Hepatocerebral degeneration is a brain disorder that occurs in people with liver damage.
This condition may occur in any case of acquired liver failure, including hepatitis.
Liver damage can lead to the build-up of ammonia and other toxic materials in the body. This happens when the liver doesn't work properly to break down and release these chemicals. The toxic materials can destroy brain tissue.
Specific areas of the brain, such as the basal ganglia, are more likely to be injured from liver failure. The basal ganglia help regulate movement.
This condition is the "Non-Wilsonian" type. This means that the liver damage is not caused by copper deposits in the liver, which is a key feature of Wilson's disease.
Symptoms may include:
A nervous system (neurological) examination may show signs of:
Laboratory tests may show a high ammonia level in the bloodstream and abnormal liver function.
Other tests may include:
Treatment helps reduce the toxic chemicals that build up from liver failure. It may include laxatives such as lactulose, which lower the level of ammonia in the blood.
A treatment called branched-chain amino acid therapy has been reported in a few patients to improve symptoms and reverse the brain damage from this condition.
There is no specific treatment for the neurologic syndrome, because it is caused by irreversible liver damage. A liver transplant may cure the liver disease. However, this operation may not reverse the symptoms of brain damage.
This is a long-term (chronic) condition that may lead to irreversible nervous system (neurological) symptoms.
The patient may continue to get worse and may die without a liver transplant. If a transplant is done early in the course of the disease, the neurological syndrome may be reversible.
Call your health care provider if you have any symptoms of liver disease.
It is not possible to prevent all forms of liver disease. However, alcoholic and viral hepatitis may be prevented.
To reduce your risk of getting alcoholic or viral hepatitis:
Chronic acquired (Non-Wilsonian) hepatocerebral degeneration